Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tuberculosis. Beating the bacillus

D B Young1

  • 1Department of Medical Microbiology, St Mary's Hospital Medical School, London, UK.

Current Biology : CB
|April 1, 1994
PubMed
Summary
This summary is machine-generated.

Researchers identified the target of isoniazid in the tuberculosis pathogen. This discovery aids in developing new drugs and diagnostics against drug-resistant tuberculosis strains.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of the breadth and complexity of bovine viral diarrhea (BVDV) populations circulating in 34 persistently infected cattle generated in one outbreak.

Virology·2015
Same author

The 65kDa antigen of mycobacteria-a common bacterial protein?

Immunology today·2014
Same author

Cloning and expression of mycobacterial genes in E. coli.

Immunology today·2014
Same author

The ongoing challenge of latent tuberculosis.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2014
Same author

Cold plate assembly for optimal paraffin block temperature.

Canadian journal of medical technology·2014
Same author

Analytical performance issues: quantifying response time in carbon monoxide monitors to produce high-resolution measurements.

Journal of occupational and environmental hygiene·2013

Area of Science:

  • Microbiology
  • Drug Discovery
  • Infectious Diseases

Background:

  • Tuberculosis remains a significant global health threat, exacerbated by rising drug resistance.
  • Isoniazid is a first-line treatment, but its precise molecular target in Mycobacterium tuberculosis has been elusive.
  • Understanding drug mechanisms is crucial for combating resistant strains.

Purpose of the Study:

  • To identify the specific molecular target of isoniazid within Mycobacterium tuberculosis.
  • To provide a foundation for developing novel therapeutic strategies against tuberculosis.
  • To facilitate the creation of new diagnostic tools for resistant tuberculosis.

Main Methods:

  • Utilized a combination of genetic screening and biochemical assays.
  • Employed proteomic analysis to identify isoniazid-interacting proteins.

Related Experiment Videos

  • Validated the target through in vitro and in vivo models.

    • Main Results:

    • Successfully identified the primary molecular target of isoniazid in Mycobacterium tuberculosis.
    • Demonstrated that disruption of this target significantly impacts bacterial survival.
    • Confirmed the target's role in isoniazid's mechanism of action.

    Conclusions:

    • The identification of the isoniazid target is a breakthrough in tuberculosis research.
    • This finding paves the way for rational drug design of new anti-tubercular agents.
    • Opens avenues for developing rapid diagnostics for isoniazid resistance.